Arne Astrup mostly deals with Internal medicine, Endocrinology, Obesity, Weight loss and Body mass index. In his work, Liraglutide is strongly intertwined with Placebo, which is a subfield of Internal medicine. His work deals with themes such as Weight gain, Glycemic index and Animal science, which intersect with Obesity.
His biological study spans a wide range of topics, including Physical therapy, Surgery, Blood pressure and Diet therapy. The study incorporates disciplines such as Glucose tolerance test, Diet Records, Anthropometry and Physiology in addition to Body mass index. While the research belongs to areas of Overweight, he spends his time largely on the problem of Food science, intersecting his research to questions surrounding Blood lipids.
His scientific interests lie mostly in Internal medicine, Endocrinology, Obesity, Weight loss and Overweight. His Internal medicine research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Type 2 diabetes. His Endocrinology research focuses on Insulin, Appetite, Thermogenesis, Adipose tissue and Postprandial.
The Appetite study combines topics in areas such as Meal and Crossover study. Arne Astrup interconnects Weight gain, Glycemic index, Food science and Environmental health in the investigation of issues within Obesity. His study in Weight loss is interdisciplinary in nature, drawing from both Placebo, Surgery, Physical therapy and Animal science.
Arne Astrup mainly investigates Internal medicine, Weight loss, Overweight, Obesity and Endocrinology. His studies deal with areas such as Diabetes mellitus and Type 2 diabetes as well as Internal medicine. His Weight loss study combines topics in areas such as Body mass index, Glycemic index and Animal science.
His Overweight study also includes fields such as
The scientist’s investigation covers issues in Weight loss, Internal medicine, Obesity, Overweight and Endocrinology. His Weight loss research incorporates themes from Biomarker, Appetite, Bioinformatics and Resting energy expenditure. His research integrates issues of Diabetes mellitus, Prediabetes and Type 2 diabetes in his study of Internal medicine.
His research in Obesity intersects with topics in Body mass index, Weight gain, Gut flora and Environmental health. His Overweight research includes elements of Feces, Blood proteins, Concordance, Metabolic syndrome and Animal science. As a part of the same scientific study, Arne Astrup usually deals with the Endocrinology, concentrating on Carbohydrate and frequently concerns with Diabetes risk and Allele.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Obesity : Preventing and managing the global epidemic
D. S. Akram;A. V. Astrup;T. Atinmo;J. L. Boissin.
World Health Organization Technical Report Series (2000)
Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies.
A Flint;A Raben;J E Blundell;A Astrup.
International Journal of Obesity (2000)
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint;A Raben;A Astrup;J J Holst.
Journal of Clinical Investigation (1998)
Effect of sibutramine on weight maintenance after weight loss: a randomised trial
W Philip T James;Arne Astrup;Nick Finer;Jannik Hilsted.
The Lancet (2000)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen;Pernelle Kruse Kristensen;Pernelle Kruse Kristensen;Else Marie Bartels;Henning Bliddal.
The Lancet (2007)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer;Arne Astrup;Ken Fujioka;Frank Greenway.
The New England Journal of Medicine (2015)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup;Stephan Rössner;Luc Van Gaal;Aila Rissanen.
The Lancet (2009)
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.
Jens M. Bruun;Aina S. Lihn;Camilla Verdich;Steen B. Pedersen.
American Journal of Physiology-endocrinology and Metabolism (2003)
Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity
AR Skov;S Toubro;B Rønn;L Holm.
International Journal of Obesity (1999)
Diets with High or Low Protein Content and Glycemic Index for Weight-Loss Maintenance
Thomas Meinert Larsen;Stine-Mathilde Dalskov;Marleen van Baak;Susan A. Jebb.
The New England Journal of Medicine (2010)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
Maastricht University Medical Centre
University of Copenhagen
University of Copenhagen
University of Copenhagen
IMDEA Food
Inserm : Institut national de la santé et de la recherche médicale
University of Copenhagen
University of Southern Denmark
University of Copenhagen
Copenhagen University Hospital
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: